Does TIRZEPATIDE Cause Injection site discolouration? 125 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 125 reports of Injection site discolouration have been filed in association with TIRZEPATIDE (Zepbound). This represents 0.1% of all adverse event reports for TIRZEPATIDE.
125
Reports of Injection site discolouration with TIRZEPATIDE
0.1%
of all TIRZEPATIDE reports
0
Deaths
2
Hospitalizations
How Dangerous Is Injection site discolouration From TIRZEPATIDE?
Of the 125 reports, 2 (1.6%) required hospitalization.
Is Injection site discolouration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TIRZEPATIDE. However, 125 reports have been filed with the FAERS database.
What Other Side Effects Does TIRZEPATIDE Cause?
Incorrect dose administered (23,301)
Injection site pain (10,989)
Nausea (10,018)
Off label use (7,007)
Extra dose administered (6,774)
Diarrhoea (5,463)
Vomiting (4,635)
Injection site haemorrhage (4,389)
Accidental underdose (3,897)
Injection site erythema (3,844)
What Other Drugs Cause Injection site discolouration?
ETANERCEPT (1,846)
DUPILUMAB (779)
CERTOLIZUMAB PEGOL (597)
ADALIMUMAB (554)
EVOLOCUMAB (476)
GLATIRAMER (270)
EXENATIDE (266)
TERIPARATIDE (249)
ASFOTASE ALFA (243)
ENBREL (231)
Which TIRZEPATIDE Alternatives Have Lower Injection site discolouration Risk?
TIRZEPATIDE vs TISAGENLECLEUCEL
TIRZEPATIDE vs TISLELIZUMAB
TIRZEPATIDE vs TISOTUMAB VEDOTIN
TIRZEPATIDE vs TISOTUMAB VEDOTIN-TFTV
TIRZEPATIDE vs TITANIUM DIOXIDE\ZINC